federal_register: 2010-1790
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010-1790 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for veterinarian prescription use of ceftiofur crystalline free acid injectable suspension for the treatment of lower respiratory tract infections in horses. | 2010-01-29 | 2010 | 1 | https://www.federalregister.gov/documents/2010/01/29/2010-1790/implantation-or-injectable-dosage-form-new-animal-drugs-ceftiofur-crystalline-free-acid | https://www.govinfo.gov/content/pkg/FR-2010-01-29/pdf/2010-1790.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA provides for... |